True Diagnostics specializes in developing portable and affordable diagnostic tests and devices based on its TrueDX Platform. The platform utilizes reliable and low-cost lab methods and proprietary or partnered biomarkers to offer rapid diagnoses in point-of-care, point-of-incidence, and remote-of-care settings. The TrueDX Platform's simplicity and flexibility make it suitable for emerging markets, and its tests have a long shelf life without refrigeration. True Diagnostics has a wide range of tests in its product pipeline, including those for cancer detection, infectious diseases, cardiac health, and drugs of abuse. The company's technology is centered around immunoassay diagnostics, and it offers a variety of immunochromatographic diagnostic devices designed to detect various human conditions.